Patent details

Basic Information

Publication number:

EP2825649

PCT Application Number:

US2013031002

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137606083

PCT Publication Number:

WO2013138505

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS

French Title of Invention:

CIBLAGE CELLULAIRE SÉLECTIF À L'AIDE D'ADÉNOVIRUS ET DE DIMÈRES CHIMIQUES

German Title of Invention:

SELEKTIVES TARGETING VON ZELLEN MITTELS ADENOVIRALER UND CHEMISCHER DIMERE

SPC Number:

Dates

Filing date:

13/03/2013

Grant date:

31/07/2019

EP Publication Date:

21/01/2015

PCT Publication Date:

19/09/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/07/2019

EP B1 Publication Date:

31/07/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/03/2020

Expiration date:

13/03/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/07/2019

 

 

Name:

The Salk Institute for Biological Studies

Address:

Office of Technology Management 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States (US)

Inventor

1

Name:

O'SHEA, Clodagh

Address:

United States (US)

2

Name:

MIYAKE-STONER, Shigeki

Address:

United States (US)

3

Name:

POWERS, Colin

Address:

United States (US)

Priority

Priority Number:

201261610416 P

Priority Date:

13/03/2012

Priority Country:

United States (US)

Classification

IPC classification:

C12N 15/861; A61K 35/761;

Publication

European Patent Bulletin

Issue number:

201931

Publication date:

31/07/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages